Highlighted as a 'hell of a company' with a direct 'Go buy the stock' recommendation due to its high capital efficiency and strong cash flow in a cornered market.

The acquisition of Pathway Medical is a significant strategic move that strengthens Doximity's competitive position by integrating a valuable AI tool and dataset. The market views the acquisition and recent double-digit revenue growth favorably.